Abiopharma

🔍 Kirk Jennifer M (Director)

Company: SEMPRA (SRE)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 128 shares of Phantom Shares (Derivative)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 4,832.43 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F4, F5

Footnotes:

• F1: Phantom shares of Sempra Common Stock acquired as director compensation.
• F2: Conversion of Derivative Security is 1 for 1.
• F3: Date exercisable is immediate for shares that have vested.
• F4: Expiration date is Not Applicable.
• F5: Total includes 1,906.10 unvested restricted phantom shares that are subject to forfeiture if service as a director terminates prior to vesting for any reason other than death, disability or removal without cause.